LOT

LOT has been reinstated to quotation after suspension, likely following completion of a capital restructuring or substantial transaction. No material exploration or production updates accompany this administrative reinstatement.

LOT has completed bookbuild for an institutional entitlement offer, likely to fund uranium exploration or development activities. Absence of run-up suggests the market had already priced in the capital requirement.

LOT's Kayelekera acid plant repairs completed with production restart targeted for early August 2026; 332 klbs YTD uranium inventory growing and ~108 klbs accepted product staged for first shipment. Company remains under voluntary suspension pending strategic funding deal critical to subsidiaries' viability, with offtake negotiations ongoing to reduce near-term delivery obligations.

Citigroup's Citi entities collectively reduced their LOT holding by ~2.9M shares through securities lending and market activity, with voting power declining from 7.70% to 6.64%. The reduction appears driven by normal trading and lending operations rather than a strategic exit.